Targeted combined therapy in 2D and 3D cultured MCF-7 cells using metformin and erlotinib-loaded mesoporous silica magnetic nanoparticles.
Nastaran HashemzadehAyuob AghanejadElaheh Dalir AbdolahiniaMitra DolatkhahMohammad Barzegar-JalaliYadollah OmidiMorteza MahmoudiKhosro AdibkiaPublished in: Journal of microencapsulation (2021)
Overall, our combined ER and MET-loaded targeted NSs result in a synergistic inhibitory impact on MCF-7 cells.